Polyvalent vaccine
AssigneesLos Alamos National Security, LLC, University of Alabama at Birmingham Research Foundation, Beth Israel Deaconess Medical Center, Inc., Duke University
InventorsBette T. KORBER, William Fischer, Hua-Xin Liao, Barton F. Haynes, Norman Letvin, Beatrice H. Hahn
Life of this patent
Estimating the term…
Abstract
The present invention relates, in general, to an immunogenic composition (e.g., a vaccine) and, in particular, to a polyvalent immunogenic composition, such as a polyvalent HIV vaccine, and to methods of using same. The invention further relates to methods that use a genetic algorithm to create sets of polyvalent antigens suitable for use, for example, in vaccination strategies.
Claims2
A polypeptide or protein comprising at least one sequence of amino acids set forth in FIG. 21.
Dependencies are inferred from the claim text.